Evaluating the Preferences and Tradeoffs of AI-based Electronic Consultations for Older Adults in Primary Care

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age65+
SponsorUniversity of Pennsylvania

About this trial

Electronic consultations, or e-consults, let a primary care doctor request medical advice from a specialist without requiring the patient to attend a separate visit. Artificial intelligence (AI) systems may be able to provide this type of advice, potentially making e-consults faster and less costly. However, whether AI-based e-consults are acceptable may depend on how patients and clinicians weigh factors such as who provides the advice, how quickly it is received, its cost, and its quality.

The purpose of this study is to examine how older adult patients and primary care clinicians weigh these factors when comparing e-consults produced by a human specialist with those produced by an AI system. In the study, participants will complete a one-time survey in which they compare sets of two hypothetical e-consults. Each e-consult will include a different combination of features, such as whether the advice comes from a human or AI, the expected wait time, the cost, and the quality of the advice. This study will estimate how much patients and clinicians value each feature in an e-consult. The findings will inform the potential future AI e-consults, so they better reflect patient and clinician preferences.

Eligibility criteria

Qualifiers

Adult, 65 years of age or older

Had at least two office visits at Penn Medicine in the past 12 months

Has an upcoming appointment in a Penn Medicine primary care setting, including family medicine, internal medicine, and geriatric medicine

Disqualifiers

Documented Alzheimer's, dementia, or related condition

Adult, 18 years of age or older

Works at Penn Medicine as one of the following: physician, nurse practitioner, or physician's assistant

Works in a primary care Penn Medicine setting including: family medicine, internal medicine, geriatrics medicine

Trial design

Treatments tested in this trial

  • Discrete Choice Experiment Survey

Treatment groups

220 Participants
are divided into 1 treatment group

Sponsors and collaborators